DUBLIN–(BUSINESS WIRE)–The “Vaccines – Global Market Outlook (2018-2027)” report has been added to ResearchAndMarkets.com’s offering.
The Global Vaccines market accounted for $38.36 billion in 2018 and is expected to reach $81.27 billion by 2027 growing at a CAGR of 8.7% during the forecast period.
While the factors like growing awareness on immunization, strong vaccine pipeline and the increasing focus of the key pharmaceutical players to develop innovative vaccines are driving the growth of the market. However, the huge capital investments required for developing vaccines may restrain the market growth. Moreover, the high growth prospects in emerging markets and an increase in the adoption of combination vaccines in prevention strategies by the government provide new growth opportunities in the future.
Based on the distribution channel, the hospital & retail pharmacies are likely to have a huge demand in the forecast period because vaccinations are a shorter duration procedure often conducted at smaller institutions. Also, people prefer nearby vaccination access. Hospital & retail pharmacies across the globe are under government surveillance to ensure vaccines demand is met and have adequate vaccine stock. By geography, North America is estimated to have a huge demand owing to the high prevalence of infectious diseases and growing investments by government and non-government organizations for vaccine development.
Some of the key players in Vaccines Market include Johnson & Johnson, Astrazeneca, Mitsubishi Tanabe Pharma Corporation, Sanofi Pasteur SA, CSL Limited, Emergent Biosolutions Inc, Panacea Biotec LTD, Bharat Biotech, Serum Institute of India Pvt LTD, Bavarian Nordic, Glaxosmithkline PLC, Daiichi Sankyo Company Limited, Pfizer Inc, Biological E, and Merck & Co Inc.
What the report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Key Topics Covered
1 Executive Summary
2 Preface
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of COVID-19
4 Porters Five Force Analysis
5 Global Vaccines Market, By Type
5.1 Introduction
5.2 Multivalent Vaccines
5.3 Monovalent Vaccines
6 Global Vaccines Market, By Technology
6.1 Introduction
6.2 Conjugate Vaccines
6.3 Recombinant Vaccines
6.4 Toxoid Vaccines
6.5 Polysaccharide Vaccines
6.6 Inactivated & Subunit Vaccines
6.7 Live Attenuated Vaccines
6.8 Viral Vaccines
7 Global Vaccines Market, By Distribution Channel
7.1 Introduction
7.2 Government Suppliers
7.3 Hospital & Retial Pharmacies
8 Global Vaccines Market, By Route of Administration
8.1 Introduction
8.2 Intradermal
8.3 Intramuscular and Subcutaneous Administration
8.4 Oral Administration
8.5 Other Routes of Administration
8.5.1 Transcutaneous (TC)
8.5.2 Nasal Route
9 Global Vaccines Market, By Disease Indication
9.1 Introduction
9.2 Cancer
9.3 Cholera
9.4 Dengue
9.5 Diphtheria, Pertussis, and Tetanus (DTP)
9.6 Hepatitis
9.7 Herpes Zoster
9.8 Human Papilloma Virus (HPV)
9.9 Influenza
9.10 Measles, Mumps, and Rubella (MMR)
9.11 Meningococcal Disease
9.12 Pneumococcal Disease
9.13 Polio
9.14 Rabies
9.15 Rotavirus
9.16 Typhoid Fever
9.17 Varicella
10 Global Vaccines Market, By End User
10.1 Introduction
10.2 Adult Vaccines
10.3 Pediatric Vaccines
10.4 Traveler Vaccines
11 Global Vaccines Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Johnson & Johnson
13.2 Astrazeneca
13.3 Mitsubishi Tanabe Pharma Corporation
13.4 Sanofi Pasteur S.A.
13.5 CSL Limited
13.6 Emergent Biosolutions Inc.
13.7 Panacea Biotec Ltd.
13.8 Bharat Biotech
13.9 Serum Institute of India Pvt. Ltd.
13.10 Bavarian Nordic
13.11 Glaxosmithkline PLC
13.12 Daiichi Sankyo Company Limited
13.13 Pfizer Inc.
13.14 Biological E
13.15 Merck & Co. Inc.
For more information about this report visit https://www.researchandmarkets.com/r/xty45p
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900